Original Source(s)
Related Content
FDA monthly preview: Key September decisions to watch
Several FDA decisions across multiple specialties are expected this month.
August 28, 2026
-
5 min
Sodium Thiosulfate for Refractory Metabolic Alkalosis From Diuretic Therapy: A Case Series of Six Patients
September 1, 2026
FDA approves hepcidin mimetic for PV
Phase 3 VERIFY results showed a 77% clinical response rate during weeks 20 to 32.
August 31, 2026
-
3 min